The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSTHP.L Regulatory News (STHP)

  • There is currently no data for STHP

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Half-year Report

28 Jan 2022 07:00

RNS Number : 8946Z
Stranger Holdings PLC
28 January 2022
 

28 January 2022

STRANGER HOLDINGS PLC

("Stranger" or the "Company")

Interim Results for the Six-Month Period Ended 30 September 2021

 

Stranger is an investment company with the original primary objective of undertaking a single acquisition of a target company, business, or asset in the industrial or service sector.

 

Chairman's Report

On 26 September 2021 the directors were pleased to announce that the company had entered into a Memorandum of Understanding with Mayflower Capital Investments Pty Limited ("Mayflower") for the acquisition of certain mineral rights in Africa, to include commodities such as Tin and Uranium. It is a very exciting opportunity for the Company; however, we are still currently unable to disclose any further details at this stage due to confidentiality reasons, but we will update the market as soon as we are able. The directors have already completed a Reverse Take-Over transaction with Mayflower via Caracal Gold PLC (formerly Papillon Holdings PLC), which they still act as directors for, and we have enjoyed an excellent working relationship with the Mayflower team and look forward to progressing this transaction with them.

 

Post 30 September, the Company provided an update on the transaction with Mayflower Capital to acquire an advance and near-term production uranium project (the 'Project') located in South Africa (the 'Acquisition'). The Project is located in the Northern Cape and close to the Namibian border and is an established uranium production jurisdiction.

 

High grade uranium mineralisation was first discovered by Anglo American in 1975 and extensive exploration programs, resource definition drilling, metallurgical test work and feasibility studies have been completed since then. The Project extends over a total area of 74,151 hectares and is covered by a granted Prospecting Right and all necessary permits and approvals are in place to allow the Company to commence exploration and update the feasibility study work.

 

The Board and its consultants are of the opinion that the Project has the potential to be developed as a near term, low cost uranium project, which benefits from excellent infrastructure with road, power and water within 2km of deposit, and which is likely to receive strong market support when the Company is re-admitted to the Official List and to trading on the main market for listed securities of the London Stock Exchange, given the strength of the uranium market.

 

In accordance with the announced Heads of Terms, the Company appointed a new non-executive director, Ms Jackline Muchai, to the Board, in December 2021 as a representative of the Project vendors, and a further a representative is to be appointed as a non-executive director on completion of its legal, financial and technical due diligence. The Company is pleased with the process that its consultants and Mayflower are making with the Acquisition and looks forward to concluding it in 2022. As part of the transaction the Company is commencing a balance sheet restructuring and is being advised by Mazars LLP.

 

Acquisitions are subject, inter alia, to the completion of due diligence, documentation and compliance with all regulatory requirements, including the Listing and Prospectus Rules and, as required, the Takeover Code. The Company will, in due course, be making an application for the enlarged Company to have its Ordinary Shares admitted to the Official List and to trading on the main market for listed securities of the London Stock Exchange.

 

The previously contemplated and announced transactions to acquire The Recyclus Group were terminated with immediate effect and we have appointed solicitors to recover monies owed to us of in the region of £390,000 plus interest and costs. The Company had received substantial further advances from the bond, which have been onward advanced to Recyclus, for which they had assumed responsibility for the servicing and ultimate repayment of the bond. There is no guarantee that we will be successful in the claim, but we are advised our claims are strong.

 

The Future

The directors look forward to completing this RTO as soon as practicable as we believe the acquisition represents an exciting and profitable opportunity for the shareholders of the Company.

 

Risks and uncertainties

The Company is a relatively new entity, with only a brief operating history, and therefore, investors have no basis on which to evaluate the Company's ability to achieve its objective of identifying, acquiring, and operating one or more companies or businesses.

 

Going Concern

As stated in the notes to the condensed financial statements, the directors are satisfied that the Company has sufficient resources to continue in operation for the foreseeable future, a period of not less than 12 months from the date of this report. Accordingly, they continue to adopt the going concern basis in preparing the condensed financial statements.

 

Responsibility Statement

We confirm that to the best of our knowledge:

(a) the condensed set of financial statements has been prepared in accordance with IAS 34 'Interim Financial Reporting';

 

(b) the interim management report includes a fair review of the information required by DTR 4.2.7R (indication of important events during the first six months and description of principal risks and uncertainties for the remaining six months of the year; and

 

(c) the interim management report includes a fair review of the information required by DTR 4.2.8R (disclosure of related parties' transactions and changes therein).

 

Cautionary statement

This Interim Management Report (IMR) has been prepared solely to provide additional information to shareholders to assess the Company's strategies and the potential for those strategies to succeed. The IMR should not be relied on by any other party or for any other purpose.

 

James Longley

Director

27 January 2022

 

INTERIM CONDENSED STATEMENT OF COMPREHENSIVE INCOME

 

 

 

6 Months ended

30 September

2021

GBP ('000)

(unaudited)

6 months ended

30 September

2020

GBP ('000)

(unaudited)

Year ended

31 March

2021

GBP ('000)

(audited)

 

 

 

 

Revenue

-

1

1

 

Administrative expenses

 

(142)

 

(117)

 

(344)

Listing costs

(1)

(1)

(12)

 

───────

───────

───────

Operating loss

(143)

(118)

(355)

 

 

 

 

Investment Income

 

 

106

Finance costs

(79)

(104)

(103)

 

───────

───────

───────

Loss before taxation

(222)

(222)

(432)

Taxation

-

-

-

 

───────

───────

───────

Loss for the period

(222)

(222)

(432)

 

═══════

═══════

═══════

 

 

 

 

Loss per share - basic and diluted (pence)

(0.15p)

(0.15p)

(0.30p)

 

───────

───────

───────

 

 

 

INTERIM CONDENSED STATEMENT OF FINANCIAL POSITION

 

 

As at

30 September

2021

GBP ('000)

(unaudited)

As at

30 September

2020

GBP ('000)

(unaudited)

As at

31 March

2021

GBP ('000)

(audited)

Assets

 

 

 

Current assets

 

 

 

Trade & other receivables

392

391

750

Cash and cash equivalents

-

-

-

 

 

 

 

Non current assets

 

 

 

Other debtors

138

135

133

 

───────

───────

───────

Total Assets

530

526

883

 

═══════

═══════

═══════

 

 

 

 

Equity and Liabilities

 

 

 

Share capital

145

145

145

Share premium

737

737

737

Profit and loss

(3,038)

(2,606)

(2,816)

 

───────

───────

───────

Total Equity

(2,156)

(1,724)

(1,934)

 

 

 

 

Current Liabilities

 

 

 

Trade and other payables

477

674

771

Borrowings

336

201

199

 

───────

───────

───────

Total current liabilities

813

875

970

 

───────

───────

───────

Long term liabilities

 

 

 

Borrowings

1,873

1,375

1,847

 

───────

───────

───────

Total long term liabilities

1,873

1,375

1,847

 

───────

───────

───────

 

 

 

 

 

───────

───────

───────

Total Liabilities

2,686

2,250

2,817

 

───────

───────

───────

Total Equity and Liabilities

530

526

883

 

═══════

═══════

═══════

 

 

INTERIM CONDENSED STATEMENT OF CHANGES IN EQUITY

 

 

 

Share Capital

 

GBP ('000)

Share premium

 

GBP ('000)

Retained earnings

 

GBP ('000)

Total

 

 

GBP ('000)

 

 

Equity at 31 March 2020

145

737

(2,384)

(1,502)

 

 

 

 

 

Loss for the period

-

-

(222)

(222)

 

──────

──────

───────

──────

Equity at 30 September 2020

145

737

(2,606)

(1,724)

 

 

 

 

 

 

 

 

 

 

Loss for the period

-

-

(210)

(210)

 

──────

──────

──────

──────

Equity at 31 March 2021

145

737

(2,816)

(1,934)

 

 

 

 

 

Loss for the Period

-

-

(222)

(222)

 

 

 

 

 

 

──────

──────

──────

──────

Equity at 30 September 2021

145

737

(3,038)

(2,156)

 

══════

══════

═══════

══════

 

 

INTERIM CONDENSED CASH FLOW STATEMENT

 

 

6 months ended

30 September

2021

GBP ('000)

(unaudited)

Period ended

30 September

2020

GBP ('000)

(unaudited)

Year ended

31 March 

2021

GBP ('000)

(audited)

 

 

 

 

Cash flows from operating activities

 

 

 

Operating loss

(222)

(222)

(432)

Add interest payable

79

104

183

(Increase)/decrease in trade and other receivables

(2)

(178)

(464)

Less interest receivable

-

(47)

(106)

Increase/(decrease) in trade and other payables

162

243

(108)

 

───────

───────

───────

Net cash flows from operating activities

17

(100)

(927)

 

 

 

 

Cashflows from investing activities

 

 

 

Amounts advanced/(repaid) to related parties

43

(21)

35

Interest received

-

47

106

Interest paid

(79)

(36)

(53)

 

───────

───────

───────

Net cash from/(used in) investing activities

 

(36)

(10)

(88)

Cash flows from financing activities

 

 

 

Net proceeds from issue of bonds

19

-

729

Convertible loan notes

-

-

-

Bank borrowing

-

50

50

 

───────

───────

───────

Net cash flows from financing activities

19

50

779

 

───────

───────

───────

Net increase in cash and cash equivalents

-

(60)

(60)

Cash and cash equivalents at the beginning of the period

-

60

60

 

───────

───────

───────

Cash and cash equivalents at the end of the period

-

-

-

 

═══════

═══════

═══════

 

 

 

NOTES TO THE UNAUDITED INTERIM CONDENSED REPORT

 

General Information

Stranger Holdings Plc ('the company') is an investment company incorporated in the United Kingdom. The address of the registered office is 27-28 Eastcastle Street London W1E 8DN. The Company was incorporated and registered in England and Wales on 22 October 2015 as a private limited company and re-registered on 14 November 2016 as a public limited company.

 

1. Basis of preparation

This announcement was approved and authorised to issue by the Board of directors on 26 January 2022.

 

The financial information in this interim report has been prepared in accordance with the International Financial Reporting Standards. IFRS comprises standards issued by the International Accounting Standards Board (IASB) and the interpretations issued by the International Financial Reporting Interpretations Committee (IFRIC) as adopted by the European Union (EU). The same accounting policies and methods of computations are used as in the most recent annual financial statements.

 

There are no IFRS, or IFRIC interpretations that are effective for the first time in this period that would be expected to have a material impact on the company.

 

The financial information has been prepared under the historical cost convention, as modified by the accounting standard for financial instruments at fair value.

 

The Directors are of the opinion that the financial information should be prepared on a going concern basis, in the light of the Company's financial resources.

 

These condensed interim financial statements for the six months ended 30 September 2021 and 30 September 2020 are unaudited and do not constitute full accounts. The comparative figures for the period ended 31 March 2021 are extracted from the 2021 audited financial statements.

 

No taxation charge has arisen for the period and the Directors have not declared an interim dividend.

 

Copies of the interim report can be found on the Company's website at ww.strangerholdingsplc.com

 

2. Loss per share

Basic loss per share is calculated by dividing the earnings attributable to ordinary shareholders by the weighted average number of ordinary shares outstanding during the period.

 

For diluted loss per share, the weighted average number of ordinary shares in issue is adjusted to assume conversion of all dilutive potential ordinary shares.

 

The calculation of basic and diluted earnings per share is based on the following figures:

 

 

6 months ended

30 September

2020

GBP ('000)

(unaudited)

Year ended

30 September

2019

GBP ('000)

(unaudited)

Year ended

31 March

2021

GBP ('000)

(audited)

 

Loss for the period

(222)

(222)

(432)

 

 

 

 

Weighted average number of

shares - basic and diluted

145,770,000

145,770,000

145,770,000

 

───────

───────

───────

Basic and diluted earnings per share

(0.15p)

(0.15p)

(0.30p)

 

───────

───────

───────

 

The basic and diluted earnings per share are the same as there were no potential dilutive shares in issue during the period.

 

3. Share Capital

 

 

As at

30 September

2021

GBP ('000)

(unaudited)

As at

30 September

2020

GBP ('000)

(unaudited)

 As at

31 March

2021

GBP ('000)

(audited)

 

145,770,000 Ordinary shares of £0.001 each

 

(145)

(145)

(145)

 

 

 

 

 

 

 

───────

───────

───────

 

4. Reports

A copy of this announcement will be mailed to shareholders and copies will be available for members of the public at the Company's Registered Office 27-28 Eastcastle Street London W1E 8DN.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
IR SEEFIWEESESF
Date   Source Headline
1st Nov 20231:58 pmRNSResult of General Meeting
5th Oct 20238:00 amRNSPosting of Prospectus
4th Oct 20234:17 pmRNSResignation of Joint Company Secretary
2nd Oct 20237:00 amRNSApproval & Publication of Prospectus
22nd Sep 20231:30 pmRNSResult of AGM
7th Sep 20235:48 pmRNSExtended Reporting Period
23rd Aug 20237:00 amRNSNotice of AGM
22nd Jun 20238:40 amRNS£3.5 Million Strategic Investment
22nd Mar 20237:00 amRNSCorporate Update
29th Dec 202210:30 amRNSHalf-year Report
30th Sep 20223:02 pmRNSFinal Results
21st Sep 20227:00 amRNSCorporate Update
26th Jul 20227:00 amRNSCorporate Update
28th Jan 20227:00 amRNSHalf-year Report
13th Dec 20214:08 pmRNSUpdate: Acquisition Uranium Asset & Director Appt
17th Nov 20217:00 amRNSHeads of Terms to Acquire Uranium Asset
1st Oct 20217:00 amRNSFinal Results
29th Sep 20217:00 amRNSUpdate
8th Apr 20217:00 amRNSPotential Acquisition Update & Directorate Change
26th Feb 20217:00 amRNSHalf-year Report
2nd Oct 202010:37 amRNSFinal Results
4th Feb 20207:00 amRNSHalf-year Report
24th Oct 20194:41 pmRNSResult of AGM
9th Oct 20197:00 amRNSHeads of Terms to Acquire Two Companies
19th Sep 20197:00 amRNSNotice of AGM and Posting of Report and Accounts
1st Aug 20197:00 amRNSFinal Results
4th Apr 20191:48 pmRNSFurther Potential Acquisition
3rd Apr 201911:52 amRNSCompany Update - Potential Acquisition
19th Mar 201910:30 amRNSCompany Update
24th Dec 20187:15 amRNSInterim Results
24th Dec 20187:00 amRNSFinal Results
15th Dec 20171:00 pmRNSInterim Results
28th Sep 201712:47 pmRNSResult of AGM
29th Aug 201712:06 pmRNSPossible Acquisition and Suspension of Listing
27th Jul 20177:00 amRNSFinal Results
22nd Feb 20174:00 pmRNSDirector Dealing
16th Jan 20177:00 amRNSPlacing
13th Jan 201710:15 amRNSFirst Day of Dealings

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.